Tyrosine Kinase Inhibitors BCL Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Threonine-Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors EGFR IGF | Colorectal Cancer | Thyroid Gland Medullary Carcinoma | Rectal Cancer | Acute Myelogenous Leukemia | Hematological Malignancies | Multiple Myeloma | Thyroid Gland Anaplastic Carcinoma | Thyroid Gland Carcinoma | Rhabdomyosarcoma | Pancreatic Ductal Adenocarcinoma |
---|---|---|---|---|---|---|---|---|---|---|
cabozantinib capsule | ||||||||||
trametinib | ||||||||||
bevacizumab + sintilimab | ||||||||||
binimetinib | ||||||||||
selinexor | ||||||||||
sorafenib | ||||||||||
EGFR inhibitor | ||||||||||
atezolizumab + cobimetinib | ||||||||||
pembrolizumab + selinexor | ||||||||||
venetoclax | ||||||||||
regorafenib | ||||||||||
SOXIRI | ||||||||||
FOLFOXIRI | ||||||||||
durvalumab + tremelimumab | ||||||||||
mTOR inhibitor | ||||||||||
IMM-6-415 | ||||||||||
cetuximab | ||||||||||
bevacizumab | ||||||||||
trametinib + AMG 479 |